Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 23.47%39.52B | 8.16%138.25B | 14.56%37.61B | 11.73%37.12B | 0.09%31.52B | 5.69%32.01B | 5.95%127.82B | 9.77%32.83B | 4.83%33.22B | 7.01%31.49B |
Cost of revenue | 21.02%30.67B | 8.48%108.48B | 12.04%29.28B | 12.20%29.53B | 1.11%24.32B | 7.89%25.35B | 6.49%100B | 11.38%26.13B | 5.93%26.32B | 6.25%24.06B |
Gross profit | 32.80%8.85B | 7.03%29.78B | 24.43%8.33B | 9.94%7.59B | -3.19%7.19B | -1.91%6.66B | 4.07%27.82B | 3.89%6.7B | 0.85%6.9B | 9.56%7.43B |
Operating expense | 15.96%5.5B | 9.34%20.73B | 15.04%5.82B | 15.05%5.28B | 3.19%4.88B | 3.65%4.74B | 4.69%18.96B | 2.30%5.06B | 3.45%4.59B | 7.80%4.73B |
Staff costs | 13.79%2.58B | 8.75%12.16B | 14.97%4.95B | 11.14%2.5B | 1.59%2.43B | 1.98%2.27B | 3.72%11.18B | 1.65%4.31B | 4.35%2.25B | 5.84%2.39B |
Selling and administrative expenses | ---- | 21.43%170M | ---- | ---- | ---- | ---- | 59.09%140M | ---- | ---- | ---- |
-General and administrative expense | ---- | 21.43%170M | ---- | ---- | ---- | ---- | 59.09%140M | ---- | ---- | ---- |
Depreciation and amortization | 0.00%61M | 7.86%1.19B | 9.44%1.01B | 0.00%62M | 0.00%62M | 0.00%61M | -4.24%1.11B | -5.05%922M | 0.00%62M | 0.00%62M |
-Depreciation | --0 | 10.10%948M | 10.10%948M | --0 | --0 | --0 | -0.92%861M | -0.92%861M | --0 | --0 |
-Amortization | 0.00%61M | 0.00%246M | 0.00%61M | 0.00%62M | 0.00%62M | 0.00%61M | -14.29%246M | -40.20%61M | 0.00%62M | 0.00%62M |
Rent and land expenses | ---- | 6.18%911M | ---- | ---- | ---- | ---- | 1.30%858M | ---- | ---- | ---- |
Other operating expenses | 18.41%2.86B | 10.97%6.29B | -4.62%-1.22B | 19.32%2.72B | 4.97%2.39B | 5.37%2.41B | 8.31%5.67B | 2.50%-1.17B | 2.66%2.28B | 10.18%2.27B |
Operating profit | 74.41%3.35B | 2.09%9.05B | 53.42%2.51B | -0.22%2.3B | -14.36%2.31B | -13.40%1.92B | 2.75%8.87B | 9.13%1.64B | -3.95%2.31B | 12.77%2.7B |
Net non-operating interest income (expenses) | -211.11%-56M | -42.86%-130M | -86.49%-69M | -40.00%-28M | 16.67%-15M | -12.50%-18M | -19.74%-91M | -23.33%-37M | -11.11%-20M | -28.57%-18M |
Non-operating interest income | ---- | 400.00%5M | ---- | ---- | ---- | ---- | -50.00%1M | ---- | ---- | ---- |
Non-operating interest expense | 211.11%56M | 54.79%113M | 173.68%52M | 40.00%28M | -16.67%15M | 12.50%18M | 17.74%73M | 18.75%19M | 11.11%20M | 28.57%18M |
Total other finance cost | ---- | 15.79%22M | ---- | ---- | ---- | ---- | 18.75%19M | ---- | ---- | ---- |
Net investment income | -17.54%94M | 47.66%347M | 182.35%96M | 287.50%62M | 29.31%75M | -10.24%114M | 71.53%235M | -37.04%34M | -54.29%16M | 241.18%58M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 49M | -64.71%-84M | 850.00%15M | -4,850.00%-99M | 0 | 0 | -8.51%-51M | -2M | 95.92%-2M | -2,450.00%-47M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | -50.00%-33M | 8,902.99%5.9B | -141.18%-7M | 28,714.29%6.01B | -57.69%-82M | -100.00%-22M | -415.38%-67M | 107.76%17M | -107.92%-21M | -271.43%-52M |
Less:Restructuring and mergern&acquisition | ---- | ---6.35B | ---484M | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
Less:Other special charges | 50.00%33M | 165.67%178M | 1,352.94%213M | -761.90%-139M | 57.69%82M | 100.00%22M | 6.35%67M | -270.00%-17M | 450.00%21M | 271.43%52M |
Less:Write off | ---- | --278M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Other non-operating income (expenses) | 28.95%98M | 105.21%197M | -866.67%-23M | 191.30%67M | 83.33%77M | 171.43%76M | 128.57%96M | 110.34%3M | 9.52%23M | 13.51%42M |
Income before tax | 69.35%3.5B | 70.01%15.27B | 52.60%2.52B | 260.92%8.31B | -11.66%2.37B | -11.83%2.07B | 3.63%8.98B | 29.52%1.65B | -13.29%2.3B | 10.63%2.68B |
Income tax | 154.36%1.23B | -1.76%3.01B | 76.08%773M | 12.04%921M | -13.09%830M | -42.89%482M | 1.29%3.06B | -8.73%439M | -5.52%822M | 11.83%955M |
Net income | 43.40%2.27B | 107.07%12.27B | 44.00%1.75B | 399.05%7.39B | -10.88%1.54B | 5.67%1.58B | 4.91%5.92B | 52.76%1.22B | -17.08%1.48B | 9.99%1.73B |
Net income continuous operations | 43.46%2.27B | 107.09%12.27B | 44.12%1.75B | 399.05%7.39B | -10.87%1.54B | 5.67%1.58B | 4.89%5.92B | 52.64%1.22B | -17.08%1.48B | 9.99%1.73B |
Noncontrolling interests | 2M | 11M | 1M | 10M | 0 | 0 | ||||
Net income attributable to the company | 43.59%2.27B | 106.87%12.25B | 43.91%1.75B | 398.31%7.38B | -10.88%1.54B | 5.67%1.58B | 4.91%5.92B | 52.76%1.22B | -17.08%1.48B | 9.99%1.73B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 43.59%2.27B | 106.87%12.25B | 43.91%1.75B | 398.31%7.38B | -10.88%1.54B | 5.67%1.58B | 4.91%5.92B | 52.76%1.22B | -17.08%1.48B | 9.99%1.73B |
Gross dividend payment | ||||||||||
Basic earnings per share | 43.55%94.5 | 106.57%509.46 | 44.06%72.78 | 398.31%306.81 | -11.04%64.04 | 5.24%65.83 | 5.24%246.63 | 51.03%50.52 | -17.36%61.57 | 10.80%71.99 |
Diluted earnings per share | 43.29%94.1 | 106.17%507.56 | 43.64%72.31 | 397.70%305.74 | -11.32%63.84 | 5.46%65.67 | 5.48%246.18 | 51.35%50.34 | -17.19%61.43 | 11.25%71.99 |
Dividend per share | 0 | 20.00%60 | 20.00%30 | 0 | 20.00%30 | 0 | 8.70%50 | 8.70%25 | 0 | 8.70%25 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |